HIV Vaccine Design

HIV is one of the world’s primary health concerns.  Researchers at Microsoft are collaborating with leading HIV scientific centers to bring together research expertise and cutting-edge computing technology in to the fight against the virus.  Computational tools are available here.

In the news

Washington Post, 2016

Geek Wire, 2013

Fast Company, 2012

Microsoft Blog, 2011

Selected references

F. Pereyra, D. Heckerman, J. Carlson, C. Kadie, D. Soghoian, D. Karel, A. Goldenthal, O. Davis, C. DeZiel, T. Lin, J. Peng, A. Piechocka, M. Carrington, and B. Walker. HIV Control Is Mediated in Part by CD8+ T-Cell Targeting of Specific Epitopes. J. Virol 88 12937-12948, Aug 2014.

J. Carlson, M. Schaefer, D. Monaco, R. Batorsky, D. Claiborne, J. Prince, M. Deymier, Z. Ende, N. Klatt, C. DeZiel, Tien-Ho Lin, J. Peng, A. Seese, R. Shapiro, J. Frater, T. Ndung’u, J. Tang, P. Goepfert, J. Gilmour, M. Price, W. Kilembe, D. Heckerman, P. Goulder, T. Allen, S. Allen, and E. Hunter. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science, 345(6193): 1254031, July 2014 (doi:10.1126/science.1254031).

R. Rubsamen, C. Herst, P. Lloyd, D. Heckerman. Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants. Vaccine 32, 4111-4116, June 2014.